Delivery Order SPE2DB20D2104-SPE2DB25FMPQQ

Award Date 4/29/25
Potential Completion Date 4/30/25
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $9,661.39, is for the delivery of Premarin 0.3 mg tablets. The contract is a firm fixed-price, non-set-aside award with a period of performance through May 1, 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,150.50, is for the delivery of Premarin 0.625 mg tablets. The contract is a Delivery Order with a Firm Fixed Price pricing type. It has an ultimate completion date of November 13, 2023. The contract is not designated with any set-aside requirements, indicating open competition. AmerisourceBergen...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, with a ceiling value of $1,014.09, is for the delivery of Premarin 1.25 mg tablets. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 14, 2025. This contract is not designated as a set-aside award. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award, valued at $4,677.48, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Premarin 0.3 mg tablets, a hormone treatment medication, over the period ending on April 24, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,212.97 firm fixed-price delivery order is for the supply of 1,000 tablets of Premarin 0.625 mg, a prescription medication. The contract has an ultimate completion date of May 23, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to supply Premarin 0.3 mg tablets to the U.S. Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $17,059.89, is a delivery order under a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. (Amerisourcebergen's parent company) and the DLA, worth up to $999,999,999.00 through November 2026. This IDC serves as a primary vehicle...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,327.89, is for the delivery of the drug Premarin 0.3 mg tablets in 100-count packages. The contract is a Firm Fixed Price Delivery Order with a final completion date of February 11, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Premarin 0.45 mg tablets. The contract is a firm-fixed price delivery order with a ceiling value of $4,025.61 and an ultimate completion date of September 13, 2024. This award does not have a set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Premarin 0.3 mg tablets. The contract, valued at $4,526.28, is a firm fixed-price delivery order with a completion date of December 16, 2021. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Premarin 1.25 mg tablets. The $1,753.61 firm fixed price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between DLA Troop Support Medical and AmerisourceBergen, which runs through November 2026. This IDC enables efficient government procurement of a comprehensive range of pharmaceutical...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB25FMPQQ
    Delivery Order

This federal contract award, valued at $1,639.36, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Premarin 0.3 mg tablets. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of April 30, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

Generated 7/29/25, 9:54 AM